Insulin Aspart

In the US, Insulin Aspart (insulin aspart systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1 and Diabetes - Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10AB05,A10AD05

CAS registry number (Chemical Abstracts Service)

0116094-23-6

Chemical Formula

C256-H381-N65-O79-S6

Molecular Weight

5826

Therapeutic Categories

Antidiabetic agent

Insulin analogue, recombinant human

Chemical Name

28B-L-aspartic acid-insulin (human)

Foreign Names

  • Insulinum aspartum (Latin)
  • Insulin aspart (German)
  • Insuline asparte (French)
  • Insulina asparta (Spanish)

Generic Names

  • Insulin Aspart (OS: BAN, USAN)
  • B28-Asp-Insulin (IS)
  • INA-X14 (IS)
  • Insulin X14 (IS)
  • Insulina asp├írtica (IS)
  • Insulin Aspart (PH: BP 2011)
  • Insulin aspart (PH: Ph. Eur. 7)
  • Insulinum aspartum (PH: Ph. Eur. 7)

Brand Names

  • Insulina Novorapid
    Novo Nordisk, Argentina
  • Novolog Mix 70/30 (30% sol./70% isoph.)
    Novo Nordisk, United States
  • Novolog
    Novo Nordisk, United States
  • Novomix
    Novo Nordisk, Turkey
  • NovoMix (30% sol./70% isoph.)
    Novo Nordisk, Australia; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Denmark; Novo Nordisk, Finland; Novo Nordisk, Hungary; Novo Nordisk, Ireland; Novo Nordisk, South Korea; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, Poland; Novo Nordisk, Portugal; Novo Nordisk, Russian Federation; Novo Nordisk, Slovenia; Novo Nordisk, Slovakia; Novo Nordisk, Thailand
  • NovoMix 30 (30% sol./70% isoph.)
    Novo Nordisk, United Kingdom; Novo Nordisk, Malaysia; Novo Nordisk, Singapore; Novo Nordisk, Taiwan; Novo Nordisk, South Africa
  • NovoMix 30 FlexPen (30% sol./70% isoph.)
    Novo Nordisk, Romania
  • NovoRapid
    Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Belgium; Novo Nordisk, Canada; Novo Nordisk, Switzerland; Novo Nordisk, Chile; Novo Nordisk, China; Novo Nordisk, Czech Republic; Novo Nordisk, Germany; Novo Nordisk, Denmark; Novo Nordisk, Spain; Novo Nordisk, Finland; Novo Nordisk, France; Novo Nordisk, United Kingdom; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Hungary; Novo Nordisk, Indonesia; Novo Nordisk, Ireland; Novo Nordisk, Israel; Novo Nordisk, India; Novo Nordisk, Japan; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Mexico; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, New Zealand; Novo Nordisk, Oman; Novo Nordisk, Philippines; Novo Nordisk, Poland; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Sweden; Novo Nordisk, Singapore; Novo Nordisk, Slovenia; Novo Nordisk, Thailand; Novo Nordisk, Turkey; Novo Nordisk, Taiwan; Novo Nordisk, South Africa
  • NovoRapid 30 Mix
    Novo Nordisk, Japan
  • NovoRapid FlexPen
    Novo Nordisk, Bangladesh; Novo Nordisk, Spain; Novo Nordisk, Georgia; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Serbia; Novo Nordisk, Tunisia
  • NovoRapid Innolet
    Novo Nordisk, Lithuania; Novo Nordisk, Latvia
  • NovoRapid NovoLet
    Novo Nordisk, Lithuania; Novo Nordisk, Latvia
  • NovoRapid Penfill
    Novo Nordisk, Bangladesh; Novo Nordisk, Czech Republic; Novo Nordisk, Georgia; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Portugal; Novo Nordisk, Romania; Novo Nordisk, Serbia
  • Insulina Novomix 30
    Novo Nordisk, Argentina
  • Novomix
    Novo Nordisk, France
  • NovoMix (30% sol./70% isoph.)
    Novo Nordisk, Indonesia; Novo Nordisk, Israel
  • NovoMix 30 (30% sol./70% isoph.)
    Novo Nordisk, Austria; Novo Nordisk, Canada; Novo Nordisk, Switzerland; Novo Nordisk, Chile; Novo Nordisk, China; Novo Nordisk, Germany; Novo Nordisk, Spain; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, India; Novo Nordisk, Mexico; Novo Nordisk, Oman; Novo Nordisk, Philippines; Novo Nordisk, Sweden
  • NovoMix 30 FlexPen (30% sol./70% isoph.)
    Novo Nordisk, Bangladesh; Novo Nordisk, Israel; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Serbia; Novo Nordisk, Tunisia; Novo Nordisk, Vietnam
  • NovoMix 30 NovoLet (30% sol./70% isoph.)
    Novo Nordisk, Latvia
  • NovoMix 30 Penfill (30% sol./70% isoph.)
    Novo Nordisk, Bangladesh; Novo Nordisk, Belgium; Novo Nordisk, Israel; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Serbia
  • NovoMix 50 (50% sol./50% isoph.)
    Novo Nordisk, Spain; Novo Nordisk, Croatia (Hrvatska)
  • NovoMix 50 FlexPen (50% sol./50% isoph.)
    Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Latvia
  • NovoMix 50 Penfill (50% sol./50% isoph.)
    Novo Nordisk, Belgium; Novo Nordisk, Lithuania; Novo Nordisk, Latvia
  • NovoMix 70 (70% sol./30% isoph.)
    Novo Nordisk, Austria; Novo Nordisk, Spain; Novo Nordisk, Croatia (Hrvatska)
  • NovoMix 70 FlexPen (70% sol./30% isoph.)
    Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Latvia
  • NovoMix 70 Penfill (70% sol./30% isoph.)
    Novo Nordisk, Belgium; Novo Nordisk, Lithuania; Novo Nordisk, Latvia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)